Secondaries announced 3.23.2016
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Vitae Pharmaceuticals, Inc. Symbol: VTAE Price: Last trade $6.73 Trade Date: 3/24 Shares: 4.45 million Underwriter(s) Piper Jaffray, BMO Capital Markets[…]